Is the 5-HT(1Dβ) receptor gene implicated in the pathogenesis of obsessive-compulsive disorder?

American Journal of Psychiatry

Volumn 157, Issue 7, 2000, Pages 1160-1161

  Mundo, Emanuela ^b   Richter, Margaret A ^b   Sam, Fariba ^b   Macciardi, Fabio ^b   Kennedy, James L ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN AGONIST; SEROTONIN RECEPTOR; SUMATRIPTAN; AUTORECEPTOR; SEROTONIN 1B RECEPTOR;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSION; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR GENE; SEROTONINERGIC SYSTEM; DRUG EFFECT; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENETICS; GENOTYPE; OBSESSIVE COMPULSIVE DISORDER;

ADULT; AUTORECEPTORS; FEMALE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; OBSESSIVE-COMPULSIVE DISORDER; POLYMORPHISM, GENETIC; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, SEROTONIN; SUMATRIPTAN; VARIATION (GENETICS);

EID: 0033624118     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.157.7.1160     Document Type: Article

References (14)

1. Sasson Y, Zohar J, Chopra M, Lustig M, Iancu I, Hendler T: Epidemiology of obsessive-compulsive disorder: a world view. J Clin Psychiatry 1997; 58(suppl 12):7-10
2. Gross R, Sasson Y, Chopra M, Zohar J: Biological models of obsessive-compulsive disorder: the serotonin hypothesis, in Obsessive-Compulsive Disorder: Theory, Research, and Treatment. Edited by Swinson RP, Antony MM, Rachman S, Richter MA. New York, Guilford, 1998, pp 147-148
3. Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC: Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder: a meta-analysis. Arch Gen Psychiatry 1995; 52:53-60
4. Nicolini H, Cruz C, Camarena B, Orozco B, Kennedy JL, King N, Weissbecker K, de la Fuente JR, Sidenberg D: DRD2, DRD3 and 5HT2A receptor genes polymorphisms in obsessive-compulsive disorder. Mol Psychiatry 1996; 1:461-465
5. Cavallini MC, Di Bella D, Pasquale L, Henin M, Bellodi L: 5HT2C CYS23/SER23 polymorphism is not associated with obsessive-compulsive disorder. Psychiatry Res 1998; 77:97-104
6. Billett EA, Richter MA, King N, Heils A, Lesch KP, Kennedy JL: Obsessive-compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene. Mol Psychiatry 1997; 2:403-406
7. McDougle CJ, Epperson CN, Price LH, Gelernter J: Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive-compulsive disorder. Mol Psychiatry 1998; 3:270-273
8. Stern L, Zohar J, Cohen R, Sasson Y: Treatment of severe, drug resistant obsessive-compulsive disorder with the 5HT1D agonist sumatriptan. Eur Neuropsychopharmacol 1998; 8:325-328
9. Lappalainen J, Dean M, Charbonneau L, Virkkunen M, Linnoila M, Goldman D: Mapping of the serotonin 5HT1Dβ autoreceptor gene on chromosome 6 and direct analysis for sequence variants. Am J Med Gen Neuropsychiatr Genet 1995; 60:157-161
10. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS: The Yale-Brown Obsessive Compulsive Scale, I: development, use, and reliability. Arch Gen Psychiatry 1989; 46:1006-1011
11. Lahiri DK, Nurnberger JI Jr: A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991; 19:5444
12. Spielman RS, Ewens WJ: A sibship test for linkage in the presence of association: the Sib Transmission/Disequilibrium Test. Am J Hum Gen 1998; 62:450-458
13. 2A receptor gene. Lancet 1995; 346:281-282
14. Mundo E, Bareggi SR, Pirola R, Bellodi L: Effects of acute intravenous clomipramine and antiobsessional response to proserotonergic drugs: is gender a predictive variable? Biol Psychiatry 1999; 45:290-294